FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/10/075691 [Registered on: 23/10/2024] Trial Registered Prospectively
Last Modified On: 07/10/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Homeopathy
Diagnostic
Screening 
Study Design  Other 
Public Title of Study   Accessing the utility of Boger Boenninghausens Characteristics Repertory in the management Bronchial Asthma. 
Scientific Title of Study   To explore the applicability of Boger Boenninghausens Characteristics Repertory in management of Bronchial asthma. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Priyanka Borse 
Designation  PG Scholer 
Affiliation  Jawaharlal Nehru Homoeopathic Medical College and Hospital 
Address  OPD 110, Jawaharlal Nehru Homoeopathic Medical College and Hospital, Parul University, Post Limda, Taluka Waghodia, Dist. Vadodara

Vadodara
GUJARAT
391760
India 
Phone  9377787774  
Fax    
Email  priyankaborse22@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Vaibhavi Chaudhari 
Designation  Assistant Professor, Repertory 
Affiliation  Jawaharlal Nehru Homoeopathic Medical College and Hospital 
Address  Jawaharlal Nehru Homoeopathic Medical College, Department of Repertory, Post Graduation Division, Parul University, Post Limda, Taluka Waghodia, Dist. Vadodara

Vadodara
GUJARAT
391760
India 
Phone  8511334512  
Fax    
Email  vaibhavi.chaudhari26118@paruluniversity.ac.in  
 
Details of Contact Person
Public Query
 
Name  Dr Priyanka Borse 
Designation  PG Scholer 
Affiliation  Jawaharlal Nehru Homoeopathic Medical College and Hospital 
Address  OPD 110, Jawaharlal Nehru Homoeopathic Medical College and Hospital, Parul University, Post Limda, Taluka Waghodia, Dist. Vadodara

Vadodara
GUJARAT
391760
India 
Phone  9377787774  
Fax    
Email  priyankaborse22@gmail.com  
 
Source of Monetary or Material Support  
OPD 110, Jawaharlal Nehru Homoeopathic Medical College and Hospital, Parul University, Post Limda, Taluka Waghodia, Dist. Vadodara, Gujarat, India - 391760 
 
Primary Sponsor  
Name  Jawaharlal Nehru Homoeopathic Medical College and Hospital 
Address  Jawaharlal Nehru Homoeopathic Medical College and Hospital at Post Limda, Taluka Waghodia, Dist. Vadodara, Gujarat, India 391760 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Priyanka Borse  Jawaharlal Nehru Homoeopathic Medical College and Hospital  Jawaharlal Nehru Homoeopathic Medical College, Department of Repertory, Post Graduation Division, Parul University, P.O. Limda, Ta. Wadhodia, 391760
Vadodara
GUJARAT 
9377787774

priyankaborse22@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Jawaharlal Nehru Homoeopathic Medical College and Hospital, Institutional Committee For Human Research  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: J45||Asthma,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Individualized Homoeopathic Medicine: Arsenic Album, Ammonium Carbonicum, Antimonium Tartaricum, Argentum Nitricum, Drosera Rotundifolia, Kali Carbonicum, Ipecacuanha  Potency: Individualized Homoeopathic medicine will be prescribed 30, 200 and 1 M Potencies and Repetition will be done according to the susceptibility of patient and principles of Organon of Medicine. Frequency of Dosage: 15 days or as per requirement of Case. Route of administration: Oral (sublingual). Duration: 3 months. 
Comparator Agent  NOT APPLICABLE  NOT APPLICABLE 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  50.00 Year(s)
Gender  Both 
Details  Pre-diagnosed Bronchial Asthma cases.
Patients of various occupations and different socio-economic status will be included. 
 
ExclusionCriteria 
Details  Patients who need intensive care and management.
Patients with irreversible pathalogical changes like emphysema.
Patients who have systemic pathalogical changes along with Bronchial Asthma.
Patients with status asthmaticus.
Pregnancy and lactating mothers.
Patients with irregular follow up.
Patients who need hospitalisation. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
It is expected from the study that it will increase the scope of BBCR in selecting individualized Homoeopathic medicine in the treatment of Bronchial Asthma and will provide good alternatives to conventional mode of treatment with no side effects.  3 Months 
 
Secondary Outcome  
Outcome  TimePoints 
To assess the severity & outcome of Bronchial Asthma symptoms before and after treatment.  3 Months 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   06/11/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This study is Prospective interventional non-randomized study. By using BBCR individualized Homoeopathic medicine will be selected for the Bronchial Asthma Patients. The primary outcome is to know the effectiveness of BBCR in cases of Bronchial Asthma Patients and also assessing the before and after treatment outcome by self made questionnaire. 
Close